Jonathan R. Medverd

Jonathan R. Medverd

Auto-generated profile, based on publicly available information

Jonathan R. Medverd

Department of Radiology, University of Washington School of Medicine , Seattle, WA 98195

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Radiology
Verified
Journal Article
Closed access
MMMahmud Mossa-Basha
Mahmud Mossa-Basha
JMJonathan Medverd
Jonathan Medverd
KLKen F. Linnau
Ken F. Linnau
JLJohn B. Lynch
John B. Lynch
MWMark H. Wener
Mark H. Wener
DSDushyant V. Sahani
Dushyant V. Sahani
The coronavirus disease 2019 (COVID- 19) pandemic initially manifested in the United States in the greater Seattle area and has rapidly progressed across the nation in the past 2 months, with the United States having the highest number of cases in the world. Radiology departments play a critical role in policy and guideline development both for the department and for the institutions, specifically in planning diagnostic screening, triage, and management of patients. In addition, radiology workflows, volumes, and access must he optimized in preparation for the expected surges in the number of patients with COVID-19. In this article, the authors discuss the processes that have been implemented at the University of Washington in managing the COVID-19 pandemic as well in preparing for patient surges, which may provide: important guidance for other radiology departments who arc in the early stages of preparation and management. (C) RSNA ,2020

20 November 2025 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
YNYee Seng Ng
Yee Seng Ng
MKMohammed M. Kanani
Mohammed M. Kanani
WIWilliam King III
William King III
ZMZachary D. Miller
Zachary D. Miller
LBLauryn Brown
Lauryn Brown
NCNathan M. Cross
Nathan M. Cross

26 May 2026 in British Journal of Radiology
Verified
Journal Article
Closed access
MKMona Kharaji
Mona Kharaji
ASAhmed A Safwat
Ahmed A Safwat
DCDan Cheng
Dan Cheng
NFNegar Firoozeh
Negar Firoozeh
MHMohamed H D Hassan
Mohamed H D Hassan
MMMahmud Mossa-Basha
Mahmud Mossa-Basha
Artificial intelligence (AI) is increasingly integrated into neuroradiology practice, with a growing number of FDA-cleared algorithms now supporting tasks ranging from acute triage to volumetric analysis. This review provides a structured overview of commercially available, FDA-regulated AI tools in neuroradiology, organized by clinical application. These include detection and prioritization of intracranial hemorrhage and large vessel occlusion, aneurysm identification on CTA, automated ASPECTS scoring, and brain tumor segmentation, as well as tools for image enhancement and quantitative analysis in neurodegenerative and demyelinating diseases. For each application, we describe the algorithm’s intended function, summarize available performance data, and highlight areas where AI can add clinical value, such as reducing time to diagnosis, improving detection of subtle findings, or standardizing measurements. We also discuss key limitations, including reduced performance outside intended-use parameters and the need for broader validation. As AI tools continue to evolve, understanding their strengths, limitations, and optimal use cases is essential to their safe and effective deployment in neuroradiology.

2 March 2026 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
GSGelareh Sadigh
Gelareh Sadigh
BBBrian W. Bresnahan
Brian W. Bresnahan
NCNathan M. Cross
Nathan M. Cross
JMJonathan R. Medverd
Jonathan R. Medverd